The transcriptomic profile clustering in this work showed that type B cHCC-ICC was genetically more similar to ICC, with enhanced expression of biliary markers (EpCAM, KRT19, and PRDM5) and frequent KRAS and IDH1 mutations. Here, KRAS is linked to intrahepatic cholangiocarcinoma.